JANA D KRAMER
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant HOLTON, KS NPI 1619947744
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant KS NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$329.20
- Category: General Payments
- Program years: PY2021–2024
- Record count: 18
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $161.22 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $161.22 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.35 | 2 |
| Amgen Inc. | $35.62 | 2 |
| Lilly USA, LLC | $31.73 | 2 |
| GlaxoSmithKline, LLC. | $19.62 | 1 |
| ABBVIE INC. | $19.57 | 1 |
| Acerta Pharma LLC | $13.33 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087139666 | Novartis Pharmaceuticals Corporation | $20.90 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087139680 | Novartis Pharmaceuticals Corporation | $20.45 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104107016 | ABBVIE INC. | $19.57 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104655665 | AstraZeneca Pharmaceuticals LP | $13.33 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116670142 | GlaxoSmithKline, LLC. | $19.62 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117602387 | Amgen Inc. | $19.28 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117602389 | Amgen Inc. | $16.34 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135690072 | Lilly USA, LLC | $16.16 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135692178 | Lilly USA, LLC | $15.57 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.